Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events guidelines good pharmacoepidemiology practices course
… current role, he is in charge of activities related to the good conduct of observational studies, such as planning and …
Webinar: Addressing Challenges in Health Equity Research Share on: Wednesday, November 8, 2023, 12 - 1pm Register Now Methods and Tools to Support Actionable Health Equity Research for the Biomedical Sciences Health equity is gaining increased interest …
Stephanie MacLeod Market Access and Outcomes Strategy Telecommuter - USA MSc, Food Science and Human Nutrition BA, Technical Journalism and Communications Colorado State University, Fort Collins, CO Stephanie MacLeod has extensive experience in scientific …
… intervention being assessed. An overall diversity rating (good, fair, poor) will be provided for race/ethnicity, sex, …
… Romin Pajouheshnia Pharmacoepidemiology and Risk Management PhD, Epidemiology … Pajouheshnia, PhD, is a Research Epidemiologist in the Pharmacoepidemiology and Risk Management group with RTI-HS. … Pajouheshnia has conducted several studies in the areas of pharmacoepidemiology, clinical epidemiology, and …
… Veena Hoffman Pharmacoepidemiology and Risk Management Telecommuter - USA … company. She is a member of the International Society for Pharmacoepidemiology and has served as a reviewer for Pharmacoepidemiology and Drug Safety and other peer-reviewed …
… her current role, she is leading activities related to the good conduct of observational studies, such as planning and …
Sarah Mitchell Health Economics Manchester, United Kingdom BSc, Physiology The University of Manchester, Manchester, United Kingdom Sarah Mitchell is a Director at RTI-HS, based in the UK. Mrs. Mitchell joined RTI-HS as a Trainee Health Economist in 2009 …
Webinar: Navigating the Complex HTA Landscape for Medtech Success Share on: Wednesday, April 17, 2024, 10 - 11am As medical technology (medtech) developers prepare for making their products available to patients and providers, navigating the HTA process …
Webinar: Strategic Planning for Orphan Drugs Share on: Tuesday, June 7, 2022, 10 - 11am Maximizing Asset Value Through Evidence Generation Planning When developing new products to treat rare diseases, it is particularly challenging to demonstrate …